The effect of probiotic, prebiotic and gut microbiota on ASD: A review and future perspectives.
Nevin Sanlier, Şule Kocabas
https://pubmed.ncbi.nlm.nih.gov/34486891/Actively Recruiting
Led by Celia Bañuls · Updated on 2025-08-05
120
Participants Needed
1
Research Sites
35 weeks
Total Duration
Researchers are exploring the potential benefits of a synbiotic supplement, combining prebiotics and beneficial bacteria, for adults with obesity who may also experience anxiety or depression. The study aims to see if this supplement can change the gut microbiota and improve metabolic, inflammatory, intestinal, and appetite-related functions, along with mood and quality of life. It is a randomized, double-blind, placebo-controlled study involving 120 adults aged 18 to 65 with a BMI between 30 and 40, some with and some without psychological disorders, to better understand the gut-brain connection in obesity and mental health. Participants will be divided into groups receiving either the synbiotic supplement or a placebo daily for 12 weeks, alongside personalized nutritional counseling from a registered dietitian. The synbiotic contains specific strains of Lactobacillus and Bifidobacterium bacteria combined with tannin-based compounds. Both groups will follow a tailored hypocaloric diet, and psychological and nutritional follow-up assessments will be conducted throughout the study. Biological samples, including blood, saliva, urine, and stool, will be collected before and after the intervention for detailed analysis. During the study, participants will undergo body composition measurements, dietary and physical activity assessments, and psychological evaluations using standardized questionnaires. Researchers will measure numerous biochemical markers related to inflammation, antioxidant capacity, gut function, neurotransmitter levels, and the diversity and metabolic activity of the gut microbiota. Advanced techniques like gene expression analysis and organ-on-chip models will be used to study the gut-brain axis mechanisms. The study will last three years, focusing on microbiota diversity and mental health improvements as primary outcomes.
CONDITIONS
Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity.
C
Celia Bañuls Morant, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Celia Bañuls
Lead Sponsor
Instituto de Salud Carlos III
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive a synbiotic supplement or placebo daily alongside a personalized hypocaloric diet guided by a registered dietitian to improve mental health and metabolic parameters in obesity.
Visits at baseline, and psychological follow-up visits at weeks 4, 6, and 12
Duration - Up to 3 years for long-term outcome measurements
Participants undergo assessments including blood, urine, saliva, and stool sample collection to evaluate biochemical, inflammatory, psychological, and microbiota changes after the intervention.
Periodic assessments post-intervention as scheduled by the study team
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Nevin Sanlier, Şule Kocabas
https://pubmed.ncbi.nlm.nih.gov/34486891/Piyarat Oraphruek, Charoonsri Chusak, Sathaporn Ngamukote...
https://pubmed.ncbi.nlm.nih.gov/37111082/Andrina Rutsch, Johan B Kantsjö, Francesca Ronchi
https://pubmed.ncbi.nlm.nih.gov/33362788/Matthias Blüher, Mohini Aras, Louis J Aronne...
https://pubmed.ncbi.nlm.nih.gov/37055715/Claire L Boulangé, Ana Luisa Neves, Julien Chilloux...
https://pubmed.ncbi.nlm.nih.gov/27098727/Tugba Ozdal, David A Sela, Jianbo Xiao...
https://pubmed.ncbi.nlm.nih.gov/26861391/Giulia Marrone, Manuela Di Lauro, Francesco Izzo...
https://pubmed.ncbi.nlm.nih.gov/38201875/Valentina Taverniti, Ranjan Koirala, Alessandro Dalla Via...
https://pubmed.ncbi.nlm.nih.gov/30699901/Silvia Molino, Natalia Andrea Casanova, José Ángel Rufián Henares...
https://pubmed.ncbi.nlm.nih.gov/31117489/Yu Du, Xin-Ran Gao, Lei Peng...
https://pubmed.ncbi.nlm.nih.gov/32529075/Celia Bañuls
Lead Sponsor
Instituto de Salud Carlos III
Collaborating Sponsor